Request Demo
Last update 09 Oct 2025
LY-3435151
Last update 09 Oct 2025
Overview
Basic Info
Drug Type Biological products |
Synonyms LY 3435151 |
Target |
Action agonists |
Mechanism CD226 agonists(CD226 molecule agonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with LY-3435151NCT04099277
A Phase 1a/1b Study of LY3435151 Administered to Patients With Advanced Solid Tumors
100 Clinical Results associated with LY-3435151
Login to view more data
100 Translational Medicine associated with LY-3435151
Login to view more data
100 Patents (Medical) associated with LY-3435151
Login to view more data
100 Deals associated with LY-3435151
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | United States | 28 Oct 2019 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Japan | 28 Oct 2019 | |
| Hepatocellular Carcinoma | Phase 1 | United States | 28 Oct 2019 | |
| Hepatocellular Carcinoma | Phase 1 | Japan | 28 Oct 2019 | |
| high grade serous adenocarcinoma of ovary | Phase 1 | United States | 28 Oct 2019 | |
| high grade serous adenocarcinoma of ovary | Phase 1 | Japan | 28 Oct 2019 | |
| Leiomyosarcoma | Phase 1 | United States | 28 Oct 2019 | |
| Leiomyosarcoma | Phase 1 | Japan | 28 Oct 2019 | |
| Malignant Fibrous Histiocytoma | Phase 1 | United States | 28 Oct 2019 | |
| Malignant Fibrous Histiocytoma | Phase 1 | Japan | 28 Oct 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 2 | llzaksebze(duqhphqvuh) = hpsmgihmpl qdzmhozwqq (zarmcawqwr, NA) View more | - | 31 Aug 2021 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free